Skip to content
BESTHRTProviders
Updated on

HRT for Low Libido During Menopause

  • Licensed clinicians only
  • 6 providers compared

Best HRT providers for low libido

Our Top Choice
Nuvella by Direct Meds logo

Up to 4 Hormones, One Price, $100 Off

9.65/10ExcellentEditorial score

Get Started from $197

Editor's pick · Reviewed October 2026
← See the full menopause provider comparisonWhere to buy HRT online →

Low Libido: what to know

Updated August 2026 · Checked by our editors

Why desire changes during menopause

Lower libido in midlife seldom has one cause. Falling estrogen thins and dries vaginal tissue, making sex uncomfortable and, understandably, less appealing. Testosterone, which women make in small but meaningful amounts, declines gradually from the thirties and contributes to desire and arousal. On top come indirect drivers: poor sleep, mood changes, tiredness, shifts in body image and relationship circumstances. Treating just one layer usually disappoints.

What hormone therapy addresses

  • ›Local estrogen: Low-dose vaginal estradiol restores tissue thickness, elasticity and lubrication. For women whose main obstacle is discomfort, this alone can change things substantially.
  • ›Systemic estrogen: Improves vaginal health along with sleep, mood and hot flashes, removing several indirect causes of low desire at once.
  • ›Testosterone for women: The Menopause Society supports a trial of low-dose testosterone for postmenopausal women with hypoactive sexual desire disorder once other causes are addressed. There is no FDA-approved female product in the US, so it is prescribed off-label by a clinician comfortable with it.
  • ›DHEA: Intravaginal DHEA is an approved option for painful sex due to menopause and is included in some bundled telehealth programs.

What improvement usually looks like

  • Comfortable sex returning within 4 to 12 weeks of local estrogen
  • Better lubrication and less irritation
  • Better sleep and mood, which lift desire indirectly
  • Spontaneous interest gradually returning over 3 to 6 months
  • Less anxiety about intimacy once discomfort resolves
  • A better response when treatment tackles several causes together

Choosing a provider for this symptom

Choose platforms whose intake asks directly about sexual function, that can prescribe both systemic and vaginal estrogen, and that will talk honestly about testosterone, including that it is off-label for women in the US and needs monitoring. Providers with a single formulation cannot address the several layers involved.

How we ranked these providers

Our editorial team evaluates each provider across weighted criteria:

30%Formulation range: Access to systemic estrogen, vaginal estrogen and DHEA options
25%Sexual health assessment: Whether the intake covers desire, arousal and pain directly
20%Testosterone willingness: Clinician comfort with evidence-based off-label testosterone and monitoring
15%Ongoing support: Follow-up to adjust if the first plan falls short
10%Cost and value: Total monthly cost across several formulations

Why desire changes in midlife

Libido is shaped by hormones, but also by sleep, stress, relationship dynamics, body image, mood, medication and pain. Falling estrogen can cause vaginal dryness and painful sex, which understandably dampens desire, while testosterone, which declines gradually from the 20s onward, plays a part in sexual interest. Treating the physical barriers first often changes the picture.

A stepwise approach to treatment

Start with the basics: treat vaginal dryness and discomfort (local estrogen is very effective), improve sleep, review medicines such as some antidepressants and blood-pressure drugs, and address mood and relationship factors, with sex therapy or counselling where useful. Systemic estrogen can help sexual function indirectly through these routes.

If low desire persists and distresses you, a short trial of transdermal testosterone may be considered. Guidelines support it for postmenopausal women with hypoactive sexual desire disorder, using products and doses matched to female physiology and monitoring blood levels. It is not licensed in every country, and male products should never be used at male doses.

Questions to ask a provider

Ask whether they will look for other contributors before prescribing testosterone, which formulation and dose they use and how they will monitor you. Be wary of anyone promising dramatic results from hormone pellets or high-dose products, which are harder to adjust and carry more side effects.

This guide is general information, not medical advice. Talk to a licensed clinician about your own symptoms and history before starting any treatment.

Related symptom guides

Menopause symptoms seldom come singly. These guides cover the ones most often reported alongside low libido.

Browse every guide in the complete symptom index, or read our complete guide to menopause care and HRT.

Frequently asked questions

Common questions about low libido and HRT.

Can HRT bring back my sex drive?

It often helps, though rarely on its own. Estrogen restores vaginal comfort and improves the sleep and mood problems that suppress desire indirectly, and some women also benefit from low-dose testosterone. Because desire has psychological and relationship sides too, the best results usually come from addressing several factors together.

Is testosterone safe for women?

Low-dose testosterone for postmenopausal women with hypoactive sexual desire disorder is supported by a global consensus statement and the Menopause Society, using doses that keep levels within the normal female range. There is no FDA-approved female product in the US, so it is off-label and needs level monitoring for effects such as acne or unwanted hair growth.

How long before I notice a difference?

Comfort improvements from vaginal estrogen typically appear within 4 to 12 weeks as tissue recovers. Desire itself responds more slowly and less predictably, so plan to reassess at three to six months rather than weeks.

Do I need systemic HRT or is vaginal estrogen enough?

If discomfort during sex is the main barrier and you have no other major menopause symptoms, low-dose vaginal estrogen alone is often enough and has minimal absorption. If you also have hot flashes, disrupted sleep or mood symptoms, systemic therapy covers more of the picture.

References

This page draws on peer-reviewed research and guidance from recognised medical organisations. Sources were current at the last review date.

  1. 1.The Menopause Society (formerly NAMS). The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. 2022;29(7):767-794.
  2. 2.American College of Obstetricians and Gynecologists (ACOG). Management of Menopausal Symptoms (Clinical Practice Guideline No. 8). Obstet Gynecol. 2023.
  3. 3.The Menopause Society. The 2023 Nonhormone Therapy Position Statement of The North American Menopause Society. Menopause. 2023;30(6):573-590.
  4. 4.The Menopause Society. The 2020 Genitourinary Syndrome of Menopause Position Statement of The North American Menopause Society. Menopause. 2020;27(9):976-992.
  5. 5.National Institute for Health and Care Excellence (NICE). Menopause: Identification and Management (NICE Guideline NG23). NICE. Updated 2024.
  6. 6.National Institute on Aging (NIH). Hormones and Menopause. U.S. National Institutes of Health.
  7. 7.Mayo Clinic Staff. Hormone Therapy: Is It Right for You?. Mayo Clinic.

Best HRT Providers is an independent information site and is not affiliated with the organisations cited above. Links are included so you can verify claims and read further. This content is not medical advice, so please consult a qualified clinician.

Ready to pick an HRT provider?

Compare every menopause HRT provider on reviews, prices and treatment options, side by side.

Compare All Providers →